EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 111 filers reported holding EPIZYME INC in Q2 2018. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $165,000 | -39.8% | 32,300 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $274,000 | +3.0% | 32,300 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $266,000 | -28.1% | 32,300 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $370,000 | +49.2% | 32,300 | +54.5% | 0.00% | 0.0% |
| Q3 2020 | $248,000 | -79.9% | 20,900 | -82.8% | 0.00% | -87.5% |
| Q3 2019 | $1,236,000 | -57.5% | 121,500 | -49.0% | 0.01% | -46.7% |
| Q2 2019 | $2,906,000 | +244.3% | 238,200 | +230.4% | 0.02% | +200.0% |
| Q1 2019 | $844,000 | +151.2% | 72,100 | +22.0% | 0.01% | +150.0% |
| Q4 2018 | $336,000 | -60.2% | 59,100 | -18.0% | 0.00% | -60.0% |
| Q3 2018 | $844,000 | -14.1% | 72,100 | -2.7% | 0.01% | -16.7% |
| Q2 2018 | $982,000 | -5.6% | 74,100 | +25.4% | 0.01% | -14.3% |
| Q1 2018 | $1,040,000 | +125.6% | 59,100 | +77.5% | 0.01% | +75.0% |
| Q4 2017 | $461,000 | 0.0% | 33,300 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $461,000 | -11.0% | 33,300 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $518,000 | -8.8% | 33,300 | 0.0% | 0.00% | -20.0% |
| Q1 2017 | $568,000 | +30.6% | 33,300 | -7.0% | 0.01% | 0.0% |
| Q4 2016 | $435,000 | +38.5% | 35,800 | +8.2% | 0.01% | +66.7% |
| Q3 2016 | $314,000 | -9.2% | 33,100 | 0.0% | 0.00% | -25.0% |
| Q2 2016 | $346,000 | +22.7% | 33,100 | +35.1% | 0.00% | +33.3% |
| Q1 2016 | $282,000 | -19.2% | 24,500 | +16.7% | 0.00% | -25.0% |
| Q4 2015 | $349,000 | +31.2% | 21,000 | +1.4% | 0.00% | +33.3% |
| Q3 2015 | $266,000 | -43.8% | 20,700 | +5.1% | 0.00% | -50.0% |
| Q2 2015 | $473,000 | +57.7% | 19,700 | +23.1% | 0.01% | +50.0% |
| Q1 2015 | $300,000 | -6.5% | 16,000 | -11.1% | 0.00% | 0.0% |
| Q4 2014 | $321,000 | -39.9% | 18,000 | -8.6% | 0.00% | -42.9% |
| Q3 2014 | $534,000 | -9.6% | 19,700 | +3.7% | 0.01% | -22.2% |
| Q2 2014 | $591,000 | +52.7% | 19,000 | +11.8% | 0.01% | +50.0% |
| Q1 2014 | $387,000 | – | 17,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 31,833,334 | $47,750,000 | 19.42% |
| MPM BioImpact LLC | 3,425,202 | $3,939,000 | 1.06% |
| Palo Alto Investors LP | 6,774,541 | $7,791,000 | 0.60% |
| Foresite Capital Management I, LLC | 143,759 | $165,000 | 0.29% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 6,603,870 | $7,594,000 | 0.23% |
| Rock Springs Capital Management LP | 7,267,696 | $8,358,000 | 0.21% |
| BP PLC | 24,687 | $28,000 | 0.16% |
| NewGen Asset Management Ltd | 250,000 | $288,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 467,836 | $538,000 | 0.07% |
| Frazier Life Sciences Management, L.P. | 739,369 | $850,000 | 0.07% |